MedPath

Strategies for Optimizing a Mailed FIT Program in Appalachia

Not Applicable
Not yet recruiting
Conditions
Colonic Neoplasms
Registration Number
NCT07173985
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Brief Summary

The proposed study is examining strategies for optimizing mailed fecal immunochemical test (FIT) programs. In doing so, it will assess the efficacy of two promising strategies, FIT kit materials and patient navigation delivery mode. These strategies may help to improve colorectal cancer screening rates.

Detailed Description

PRIMARY OBJECTIVES:

Determine the efficacy of two strategies for increasing colorectal cancer screening.

OUTLINE: Participants are randomized to 1 of 4 groups.

GROUP I: Participants receive a standard FIT kit plus telephone patient navigation.

GROUP II: Participants receive a standard FIT kit plus text message patient navigation.

GROUP III: Participants receive an enhanced FIT kit plus telephone patient navigation.

GROUP IV: Participants receive an enhanced FIT kit plus text message patient navigation.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Resident of an Appalachian county
  • Medical visit at a participating health system in the past two years
  • Average-risk for colorectal cancer
  • Not currently within colorectal cancer screening guidelines
Exclusion Criteria

-

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
FIT ReturnWithin 8 weeks of FIT kit distribution

Proportion of participants who return of a completed FIT kit

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

Ohio State University Comprehensive Cancer Center
πŸ‡ΊπŸ‡ΈColumbus, Ohio, United States
Paul Reiter, PhD
Contact
614-292-4803
reiter.36@osu.edu
Paul Reiter
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.